{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T02:59:09Z","timestamp":1780887549191,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05035-8","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T16:15:57Z","timestamp":1777047357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LncRNA MCM3AP-AS1 is a potential prognostic marker for osteosarcoma and promotes its development by targeting miR-205-5p"],"prefix":"10.1007","volume":"17","author":[{"given":"Yanbing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang-Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Na","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"3","key":"5035_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/PAP.0000000000000293","volume":"28","author":"JH Choi","year":"2021","unstructured":"Choi JH, Ro JY. The 2020 WHO Classification of Tumors of Bone: An Updated Review. Adv Anat Pathol. 2021;28(3):119\u201338.","journal-title":"Adv Anat Pathol"},{"issue":"Suppl 2","key":"5035_CR2","doi-asserted-by":"publisher","first-page":"e28352","DOI":"10.1002\/pbc.28352","volume":"68","author":"BR Eaton","year":"2021","unstructured":"Eaton BR, Schwarz R, Vatner R, Yeh B, Claude L, Indelicato DJ, et al. Osteosarcoma Pediatr blood cancer. 2021;68(Suppl 2):e28352.","journal-title":"Osteosarcoma Pediatr blood cancer"},{"issue":"2","key":"5035_CR3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/bph.15713","volume":"179","author":"Z Shoaib","year":"2022","unstructured":"Shoaib Z, Fan TM, Irudayaraj JMK. Osteosarcoma mechanobiology and therapeutic targets. Br J Pharmacol. 2022;179(2):201\u201317.","journal-title":"Br J Pharmacol"},{"key":"5035_CR4","doi-asserted-by":"publisher","first-page":"e210823220109","DOI":"10.2174\/1874467217666230821142839","volume":"17","author":"S Wang","year":"2024","unstructured":"Wang S, Ren Q, Li G, Zhao X, Zhao X, Zhang Z. The Targeted Therapies for Osteosarcoma via Six Major Pathways. Curr Mol Pharmacol. 2024;17:e210823220109.","journal-title":"Curr Mol Pharmacol"},{"issue":"2","key":"5035_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"5035_CR6","doi-asserted-by":"publisher","first-page":"862","DOI":"10.2174\/0109298665335550241011080252","volume":"31","author":"S Tripathi","year":"2024","unstructured":"Tripathi S, Sharma Y, Kumar D. Exploring the Therapeutic Potential of Noncoding RNAs in Alzheimer\u2019s Disease. Protein Pept Lett. 2024;31(11):862\u201383.","journal-title":"Protein Pept Lett"},{"key":"5035_CR7","doi-asserted-by":"crossref","unstructured":"Wang JY, Yang Y, Ma Y, Wang F, Xue A, Zhu J, et al. Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma. Volume 121. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie; 2020. p. 109627.","DOI":"10.1016\/j.biopha.2019.109627"},{"key":"5035_CR8","doi-asserted-by":"publisher","first-page":"e18761429308361","DOI":"10.2174\/0118761429308361240823061634","volume":"17","author":"L Qiong","year":"2024","unstructured":"Qiong L, Shuyao X, Shan X, Qian F, Jiaying T, Yao X, et al. Recent Advances in the Glycolytic Processes Linked to Tumor Metastasis. Curr Mol Pharmacol. 2024;17:e18761429308361.","journal-title":"Curr Mol Pharmacol"},{"issue":"3","key":"5035_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3892\/ol.2021.12486","volume":"21","author":"Y Yu","year":"2021","unstructured":"Yu Y, Lai S, Peng X. Long non-coding RNA MCM3AP-AS1 facilitates colorectal cancer progression by regulating the microRNA-599\/ARPP19 axis. Oncol Lett. 2021;21(3):225.","journal-title":"Oncol Lett"},{"issue":"1","key":"5035_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s13577-021-00648-3","volume":"35","author":"C Yang","year":"2022","unstructured":"Yang C, Xu X, Lin P, Luo B, Luo S, Huang H, et al. Overexpression of long noncoding RNA MCM3AP-AS1 promotes osteogenic differentiation of dental pulp stem cells via miR-143-3p\/IGFBP5 axis. Hum Cell. 2022;35(1):150\u201362.","journal-title":"Hum Cell"},{"key":"5035_CR11","doi-asserted-by":"publisher","first-page":"155805","DOI":"10.1016\/j.cyto.2022.155805","volume":"152","author":"F Xu","year":"2022","unstructured":"Xu F, Hu QF, Li J, Shi CJ, Luo JW, Tian WC, et al. SOX4-activated lncRNA MCM3AP-AS1 aggravates osteoarthritis progression by modulating miR-149-5p\/Notch1 signaling. Cytokine. 2022;152:155805.","journal-title":"Cytokine"},{"issue":"1","key":"5035_CR12","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1080\/21655979.2021.1905247","volume":"12","author":"J Shi","year":"2021","unstructured":"Shi J, Cao F, Chang Y, Xin C, Jiang X, Xu J, et al. Long non-coding RNA MCM3AP-AS1 protects chondrocytes ATDC5 and CHON-001 from IL-1\u03b2-induced inflammation via regulating miR-138-5p\/SIRT1. Bioengineered. 2021;12(1):1445\u201356.","journal-title":"Bioengineered"},{"issue":"16","key":"5035_CR13","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.2174\/1389557522666220214100718","volume":"22","author":"B Wang","year":"2022","unstructured":"Wang B, Chen J, Lin C, Liu R, Wang L, Yuan C. MCM3AP-AS1: A LncRNA Participating in the Tumorigenesis of Cancer Through Multiple Pathways. Mini Rev Med Chem. 2022;22(16):2138\u201345.","journal-title":"Mini Rev Med Chem"},{"issue":"1","key":"5035_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12094-022-02904-w","volume":"25","author":"S Azizidoost","year":"2023","unstructured":"Azizidoost S, Ghaedrahmati F, Sheykhi-Sabzehpoush M, Uddin S, Ghafourian M, Mousavi Salehi A, et al. The role of LncRNA MCM3AP-AS1 in human cancer. Clin translational oncology: official publication Federation Span Oncol Soc Natl Cancer Inst Mexico. 2023;25(1):33\u201347.","journal-title":"Clin translational oncology: official publication Federation Span Oncol Soc Natl Cancer Inst Mexico"},{"key":"5035_CR15","doi-asserted-by":"publisher","first-page":"153303382199006","DOI":"10.1177\/1533033821990064","volume":"20","author":"Y Chen","year":"2021","unstructured":"Chen Y, Chen Z, Mo J, Pang M, Chen Z, Feng F, et al. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer. Technol Cancer Res Treat. 2021;20:1533033821990064.","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"5035_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12935-022-02644-5","volume":"22","author":"S Ghafouri-Fard","year":"2022","unstructured":"Ghafouri-Fard S, Khoshbakht T, Hussen BM, Taheri M, Samadian M. A review on the role of MCM3AP-AS1 in the carcinogenesis and tumor progression. Cancer Cell Int. 2022;22(1):225.","journal-title":"Cancer Cell Int"},{"key":"5035_CR17","doi-asserted-by":"crossref","unstructured":"Wang M, Li W, Han G, Bai X, Xie J. MicroRNA-605-3p Inhibited the Growth and Chemoresistance of Osteosarcoma Cells via Negatively Modulating RAF1. Protein and peptide letters. 2024;31(7):559\u201368.","DOI":"10.2174\/0109298665314658240712051206"},{"issue":"7","key":"5035_CR18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2174\/156800961407140926105634","volume":"14","author":"H Vosgha","year":"2014","unstructured":"Vosgha H, Salajegheh A, Smith RA, Lam AK. The important roles of miR-205 in normal physiology, cancers and as a potential therapeutic target. Curr Cancer Drug Targets. 2014;14(7):621\u201337.","journal-title":"Curr Cancer Drug Targets"},{"issue":"2","key":"5035_CR19","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s13577-019-00301-0","volume":"33","author":"H Liu","year":"2020","unstructured":"Liu H, Li A, Sun Z, Zhang J, Xu H. Long non-coding RNA NEAT1 promotes colorectal cancer progression by regulating miR-205-5p\/VEGFA axis. Hum Cell. 2020;33(2):386\u201396.","journal-title":"Hum Cell"},{"key":"5035_CR20","doi-asserted-by":"crossref","unstructured":"Valenti F, Sacconi A, Ganci F, Grasso G, Strano S, Blandino G et al. The miR-205-5p\/BRCA1\/RAD17 Axis Promotes Genomic Instability in Head and Neck Squamous Cell Carcinomas. Cancers. 2019;11(9).","DOI":"10.3390\/cancers11091347"},{"key":"5035_CR21","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2147\/CMAR.S231872","volume":"12","author":"YP Liu","year":"2020","unstructured":"Liu YP, Wan J, Long F, Tian J, Zhang C. circPVT1 Facilitates Invasion and Metastasis by Regulating miR-205-5p\/c-FLIP Axis in Osteosarcoma. Cancer Manage Res. 2020;12:1229\u201340.","journal-title":"Cancer Manage Res"},{"key":"5035_CR22","doi-asserted-by":"crossref","unstructured":"Bozycki L, Mroczek J, Bessueille L, Mebarek S, Buchet R, Pikula S et al. Annexins A2, A6 and Fetuin-A Affect the Process of Mineralization in Vesicles Derived from Human Osteoblastic hFOB 1.19 and Osteosarcoma Saos-2 Cells. Int J Mol Sci. 2021;22(8).","DOI":"10.3390\/ijms22083993"},{"issue":"5","key":"5035_CR23","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.7150\/jca.91579","volume":"15","author":"H Lin","year":"2024","unstructured":"Lin H, Wei X, Ye J, Chen J, Huang J, Wu T, et al. Lnc-CLSTN2-1:1 Promotes Osteosarcoma Progression by Disrupting Redox Balance through PI3K\/AKT Signaling Pathway. J Cancer. 2024;15(5):1287\u201398.","journal-title":"J Cancer"},{"issue":"1","key":"5035_CR24","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/jcp.26923","volume":"234","author":"D Ren","year":"2018","unstructured":"Ren D, Zheng H, Fei S, Zhao JL. MALAT1 induces osteosarcoma progression by targeting miR-206\/CDK9 axis. J Cell Physiol. 2018;234(1):950\u20137.","journal-title":"J Cell Physiol"},{"issue":"9","key":"5035_CR25","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1007\/s00432-023-04614-4","volume":"149","author":"S Li","year":"2023","unstructured":"Li S, Zhang H, Liu J, Shang G. Targeted therapy for osteosarcoma: a review. J Cancer Res Clin Oncol. 2023;149(9):6785\u201397.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"5035_CR26","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen LL, et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023;24(6):430\u201347.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5035_CR27","doi-asserted-by":"crossref","unstructured":"Ghafouri-Fard S, Shirvani-Farsani Z, Hussen BM, Taheri M. The critical roles of lncRNAs in the development of osteosarcoma. Volume 135. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie; 2021. p. 111217.","DOI":"10.1016\/j.biopha.2021.111217"},{"key":"5035_CR28","doi-asserted-by":"publisher","first-page":"742789","DOI":"10.3389\/fonc.2021.742789","volume":"11","author":"S Vimalraj","year":"2021","unstructured":"Vimalraj S, Subramanian R, Dhanasekaran A. LncRNA MALAT1 Promotes Tumor Angiogenesis by Regulating MicroRNA-150-5p\/VEGFA Signaling in Osteosarcoma: In-Vitro and In-Vivo Analyses. Front Oncol. 2021;11:742789.","journal-title":"Front Oncol"},{"issue":"4","key":"5035_CR29","first-page":"3002","volume":"18","author":"K Sheng","year":"2019","unstructured":"Sheng K, Li Y. LncRNA TUG1 promotes the development of osteosarcoma through RUNX2. Experimental therapeutic Med. 2019;18(4):3002\u20138.","journal-title":"Experimental therapeutic Med"},{"issue":"5","key":"5035_CR30","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2174\/1386207326666230602122618","volume":"27","author":"N Wan","year":"2024","unstructured":"Wan N, Liu Q, Shi J, Wang S. LncRNA SNHG25 Predicts Poor Prognosis and Promotes Progression in Osteosarcoma via the miR-497-5p\/SOX4 Axis. Comb Chem High Throughput Screen. 2024;27(5):725\u201344.","journal-title":"Comb Chem High Throughput Screen"},{"issue":"5","key":"5035_CR31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1053\/j.semnuclmed.2021.10.001","volume":"52","author":"A Farina","year":"2022","unstructured":"Farina A, Gasperini C, Aparisi G\u00f3mez MP, Bazzocchi A, Fanti S, Nanni C. The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma. Semin Nucl Med. 2022;52(5):635\u201346.","journal-title":"Semin Nucl Med"},{"issue":"3","key":"5035_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4103\/0019-5413.132497","volume":"48","author":"N Wadhwa","year":"2014","unstructured":"Wadhwa N, Osteosarcoma. Diagnostic dilemmas in histopathology and prognostic factors. Indian J Orthop. 2014;48(3):247\u201354.","journal-title":"Indian J Orthop"},{"issue":"6","key":"5035_CR33","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/cam4.1022","volume":"6","author":"SH Kim","year":"2017","unstructured":"Kim SH, Shin KH, Moon SH, Jang J, Kim HS, Suh JS, et al. Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma. Cancer Med. 2017;6(6):1311\u201322.","journal-title":"Cancer Med"},{"issue":"19","key":"5035_CR34","doi-asserted-by":"publisher","first-page":"e0741","DOI":"10.1097\/MD.0000000000010741","volume":"97","author":"Y Fu","year":"2018","unstructured":"Fu Y, Lan T, Cai H, Lu A, Yu W. Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma. Medicine. 2018;97(19):e0741.","journal-title":"Medicine"},{"issue":"1","key":"5035_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-019-0957-7","volume":"18","author":"Y Wang","year":"2019","unstructured":"Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu Q, et al. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p\/FOXA1 axis. Mol Cancer. 2019;18(1):28.","journal-title":"Mol Cancer"},{"issue":"1","key":"5035_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s10020-019-0121-2","volume":"25","author":"M Yang","year":"2019","unstructured":"Yang M, Sun S, Guo Y, Qin J, Liu G. Long non-coding RNA MCM3AP-AS1 promotes growth and migration through modulating FOXK1 by sponging miR-138-5p in pancreatic cancer. Mol Med (Cambridge Mass). 2019;25(1):55.","journal-title":"Mol Med (Cambridge Mass)"},{"key":"5035_CR37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3389\/fnmol.2017.00437","volume":"10","author":"C Yang","year":"2017","unstructured":"Yang C, Zheng J, Xue Y, Yu H, Liu X, Ma J, et al. The Effect of MCM3AP-AS1\/miR-211\/KLF5\/AGGF1 Axis Regulating Glioblastoma Angiogenesis. Front Mol Neurosci. 2017;10:437.","journal-title":"Front Mol Neurosci"},{"key":"5035_CR38","doi-asserted-by":"crossref","unstructured":"Karagkouni D, Karavangeli A, Paraskevopoulou MD, Hatzigeorgiou AG. Characterizing miRNA-lncRNA Interplay. Methods Mol biology (Clifton NJ). 2021;2372:243\u201362.","DOI":"10.1007\/978-1-0716-1697-0_21"},{"issue":"8","key":"5035_CR39","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1089\/dna.2019.4770","volume":"38","author":"H Zhang","year":"2019","unstructured":"Zhang H, Luo C, Zhang G. LncRNA MCM3AP-AS1 Regulates Epidermal Growth Factor Receptor and Autophagy to Promote Hepatocellular Carcinoma Metastasis by Interacting with miR-455. DNA Cell Biol. 2019;38(8):857\u201364.","journal-title":"DNA Cell Biol"},{"issue":"7","key":"5035_CR40","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1136\/jim-2020-001415","volume":"68","author":"H Li","year":"2020","unstructured":"Li H, Jiang J. LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p\/FOXC1. J Invest medicine: official publication Am Federation Clin Res. 2020;68(7):1282\u20138.","journal-title":"J Invest medicine: official publication Am Federation Clin Res"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05035-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05035-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05035-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T02:16:04Z","timestamp":1780884964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05035-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5035"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05035-8","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Zhucheng People\u2019s Hospital. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"860"}}